The primary side effect is nausea when you first start the medicine, which usually fades away over time
(PubMed) Yoritaka A, Kawajiri S, Yamamoto Y, et al
147 QuinlanC
The classification helps answer the question: "What am I actually taking, and how does it compare to what I read about online?" [Diagram suggestion: Four-quadrant matrix with axes labeled "Receptor target" (pure GLP-1 vs multi-agonist) and "Approval status" (FDA-approved vs compounded), with all medications plotted in their respective quadrants] The pattern we see in FormBlends refill data: patients often start on compounded semaglutide (Tier 4), then switch to brand-name Wegovy (Tier 1) when insurance coverage becomes available, then switch to tirzepatide (Tier 3) if weight loss plateaus
NSAIDs have been evaluated in several clinical trials, and there is evidence that when applied locally, they can reduce inflammation after cataract surgery (Kim 2010)
It can also be used to predict which of two substances is likely to be more soluble in water and which of two substances is likely to be more soluble in a nonpolar solvent, such as hexane: Polar substances are likely to dissolve in polar solvents